Autosomal Dominant Polycystic Kidney DiseaseSymptoms, Doctors, Treatments, Advances & More
Learn About Autosomal Dominant Polycystic Kidney Disease
- Autosomal dominant polycystic kidney disease
- ADPKD
- Polycystic kidney disease, adult type
Emory University Hospital Midtown
Frederic Oskoui is an Intensive Care Medicine provider practicing medicine in Atlanta, Georgia. He has been practicing medicine for over 6 years. Dr. Oskoui is rated as an Elite provider by MediFind in the treatment of Autosomal Dominant Polycystic Kidney Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Autosomal Dominant Polycystic Kidney Disease, Polycystic Kidney Disease, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD). Dr. Oskoui is board certified in American Board Of Anesthesiology, 2025.
Medical Pavilion
Alan Yu is a Nephrologist practicing medicine in Kansas City, Kansas. He has been practicing medicine for over 37 years. Dr. Yu is rated as an Elite provider by MediFind in the treatment of Autosomal Dominant Polycystic Kidney Disease. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Chronic Kidney Disease, Kidney Stones, and Kidney Transplant. Dr. Yu is board certified in American Board Of Internal Medicine, Nephrology - 1996 and American Board Of Internal Medicine, Internal Medicine - 1995. Dr. Yu is currently accepting new patients.
Nephrology And Hypertension Faculty Practice
Dr. Meyeon Park is a nephrologist who cares for patients affected in various ways by high blood pressure and kidney disease. She has a special focus on polycystic kidney disease (PKD) and directs UCSF's PKD center of excellence. Park's research explores how heart disease and kidney disease influence each other. She is particularly interested in learning how lifestyle changes can help individuals with PKD. Park earned her medical degree from the Perelman School of Medicine at the University of Pennsylvania. She then completed a residency in internal medicine at the Yale School of Medicine, followed by a fellowship in nephrology at UCSF. She also has a master of advanced study degree in clinical research from UCSF. Park is a member of the American Society of Nephrology. Dr. Park is rated as an Elite provider by MediFind in the treatment of Autosomal Dominant Polycystic Kidney Disease. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Polycystic Kidney Disease, Autosomal Dominant Polycystic Kidney Disease, Liddle Syndrome, Pseudohypoaldosteronism Type 2, and Kidney Transplant. Dr. Park is board certified in American Board Of Internal Medicine, Nephrology and American Board Of Internal Medicine, Internal Medicine. Dr. Park is currently accepting new patients.
Summary: The purpose of the study is to evaluate the effect of VX-407 on height-adjusted total kidney volume (htTKV), safety, tolerability, and pharmacokinetics (PK) of VX-407.
Summary: This study will investigate if a medication (metformin) widely used in the treatment of diabetes could be re-purposed for the treatment of patients with a diagnosis of early stage ADPKD to slow the rate of kidney function decline, reducing morbidity and mortality and improving the quality of life for ADPKD patients.
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center